Lung ultrasound score for monitoring the withdrawal of extracorporeal membrane oxygenation on neonatal acute respiratory distress syndrome
Extracorporeal membrane oxygenation (ECMO) is considered an efficient and life-saving treatment for neonatal severe acute respiratory distress syndrome (ARDS).1 However, ECMO also brings many inevitable complications, such as the inflammatory response to extracorporeal circulation, bleeding, thrombosis risks, etc. Weaning off ECMO should be considered immediately when neonatal ARDS patients recover from reversible pulmonary disease.2 Bedside lung ultrasound (LUS) is an attractive and feasible method for evaluating neonatal ARDS.
Source: Heart and Lung - Category: Intensive Care Authors: Hong-Lin Wu, Si-Jia Zhou, Xiu-Hua Chen, Hua Cao, Yi-Rong Zheng, Qiang Chen Source Type: research
More News: Bleeding | Cardiology | Heart | Intensive Care | Perinatology & Neonatology | Pulmonary Thromboembolism | Respiratory Medicine | Thrombosis | Ultrasound